| Dr David Neal Brown, MD | |
|
2848 Niles Rd, Saint Joseph, MI 49085-3352 | |
| (269) 428-3300 | |
| (269) 428-5005 |
| Full Name | Dr David Neal Brown |
|---|---|
| Gender | Male |
| Speciality | Ophthalmology |
| Experience | 33 Years |
| Location | 2848 Niles Rd, Saint Joseph, Michigan |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1265437370 | NPI | - | NPPES |
| 103163046 | Medicaid | MI | |
| 3153166 | Medicaid | MI |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207W00000X | Ophthalmology | 4301066138 (Michigan) | Primary |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Great Lakes Eye Care Pc | 8426091992 | 12 |
News Archive
PolyMedix, Inc., an emerging biotechnology company focused on developing new therapeutic drugs to treat acute cardiovascular disorders and infectious diseases, has successfully completed a second Phase 1B clinical safety and pilot efficacy study with PMX-60056, a small synthetic molecule designed to reverse heparin and low molecular weight heparin anticoagulants.
Kenneth D. Steinsapir, M.D., has been issued a rare patent (US 7,846,457 B2) by The United States Patent and Trademark Office for the invention of a breakthrough method for administering cosmetic botulinum toxin. The patent for Microdroplet botulinum toxin, a nonsurgical cosmetic facial treatment that improves upon standard BOTOX treatments, was officially approved on December 7, 2010.
As health reform proposals emerge from congressional committees, partisan fighting boils and the president wades into the debate with a series of televised addresses, news reports turn to an unanswered question. "What's in it for me?" asks David Leonhardt, the New York Times business columnist. "On the subject of health care reform, most Americans probably don't have a good answer to the question. And that, obviously, is a problem for the White House and for Democratic leaders in Congress," he writes.
Is it possible to prevent mental health problems in higher education students? The answer is "yes" according to a team of psychologists from Loyola University Chicago who conducted a careful, systematic review of 103 universal interventions involving over 10,000 students enrolled in 2- and 4-year colleges and universities and graduate programs.
› Verified 2 days ago
| Entity Name | Great Lakes Eye Care Pc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1922002708 PECOS PAC ID: 8426091992 Enrollment ID: O20050606000765 |
News Archive
PolyMedix, Inc., an emerging biotechnology company focused on developing new therapeutic drugs to treat acute cardiovascular disorders and infectious diseases, has successfully completed a second Phase 1B clinical safety and pilot efficacy study with PMX-60056, a small synthetic molecule designed to reverse heparin and low molecular weight heparin anticoagulants.
Kenneth D. Steinsapir, M.D., has been issued a rare patent (US 7,846,457 B2) by The United States Patent and Trademark Office for the invention of a breakthrough method for administering cosmetic botulinum toxin. The patent for Microdroplet botulinum toxin, a nonsurgical cosmetic facial treatment that improves upon standard BOTOX treatments, was officially approved on December 7, 2010.
As health reform proposals emerge from congressional committees, partisan fighting boils and the president wades into the debate with a series of televised addresses, news reports turn to an unanswered question. "What's in it for me?" asks David Leonhardt, the New York Times business columnist. "On the subject of health care reform, most Americans probably don't have a good answer to the question. And that, obviously, is a problem for the White House and for Democratic leaders in Congress," he writes.
Is it possible to prevent mental health problems in higher education students? The answer is "yes" according to a team of psychologists from Loyola University Chicago who conducted a careful, systematic review of 103 universal interventions involving over 10,000 students enrolled in 2- and 4-year colleges and universities and graduate programs.
› Verified 2 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr David Neal Brown, MD 2848 Niles Rd, Saint Joseph, MI 49085-3352 Ph: (269) 428-3300 | Dr David Neal Brown, MD 2848 Niles Rd, Saint Joseph, MI 49085-3352 Ph: (269) 428-3300 |
News Archive
PolyMedix, Inc., an emerging biotechnology company focused on developing new therapeutic drugs to treat acute cardiovascular disorders and infectious diseases, has successfully completed a second Phase 1B clinical safety and pilot efficacy study with PMX-60056, a small synthetic molecule designed to reverse heparin and low molecular weight heparin anticoagulants.
Kenneth D. Steinsapir, M.D., has been issued a rare patent (US 7,846,457 B2) by The United States Patent and Trademark Office for the invention of a breakthrough method for administering cosmetic botulinum toxin. The patent for Microdroplet botulinum toxin, a nonsurgical cosmetic facial treatment that improves upon standard BOTOX treatments, was officially approved on December 7, 2010.
As health reform proposals emerge from congressional committees, partisan fighting boils and the president wades into the debate with a series of televised addresses, news reports turn to an unanswered question. "What's in it for me?" asks David Leonhardt, the New York Times business columnist. "On the subject of health care reform, most Americans probably don't have a good answer to the question. And that, obviously, is a problem for the White House and for Democratic leaders in Congress," he writes.
Is it possible to prevent mental health problems in higher education students? The answer is "yes" according to a team of psychologists from Loyola University Chicago who conducted a careful, systematic review of 103 universal interventions involving over 10,000 students enrolled in 2- and 4-year colleges and universities and graduate programs.
› Verified 2 days ago
Dr. Benjamin P Nicholson, M.D., M.A. Ophthalmology Medicare: Accepting Medicare Assignments Practice Location: 2848 Niles Rd, Saint Joseph, MI 49085 Phone: 269-428-3300 Fax: 269-428-5005 | |
Dr. Gary Ludwig, O.D. Ophthalmology Medicare: Accepting Medicare Assignments Practice Location: 1101 Main St, Saint Joseph, MI 49085 Phone: 269-983-3461 | |
Dr. Stanley W Pletcher, M.D. Ophthalmology Medicare: Accepting Medicare Assignments Practice Location: 2848 Niles Rd, Saint Joseph, MI 49085 Phone: 269-428-3300 Fax: 269-428-5005 | |
Rikki S Enzor, MD, PHD Ophthalmology Medicare: Accepting Medicare Assignments Practice Location: 2848 Niles Rd, Saint Joseph, MI 49085 Phone: 269-428-3300 | |
Dr. Ronald L. Mckey, M.D. Ophthalmology Medicare: Accepting Medicare Assignments Practice Location: 2848 Niles Rd, Saint Joseph, MI 49085 Phone: 269-428-3300 Fax: 269-428-5005 | |
Jason Min So, MD Ophthalmology Medicare: Accepting Medicare Assignments Practice Location: 2848 Niles Rd, Saint Joseph, MI 49085 Phone: 269-428-3300 |